|
1
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zheng Y, Ley SH and Hu FB: Global
aetiology and epidemiology of type 2 diabetes mellitus and its
complications. Nat Rev Endocrino. 14:88–98. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hellstrom HR: The altered homeostatic
theory: A hypothesis proposed to be useful in understanding and
preventing ischemic heart disease, hypertension, and
diabetes-including reducing the risk of age and atherosclerosis.
Med Hypotheses. 68:415–433. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Maggiore U, Budde K, Heemann U, Hilbrands
L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky
O and Abramowicz D: ERA-EDTA DESCARTES working group. Long-term
risks of kidney living donation: Review and position paper by the
ERA-EDTA DESCARTES working group. Nephrol Dial Transplant.
32:216–223. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sagoo MK and Gnudi L: Diabetic
nephropathy: An overview. Methods Mol Biol. 2067:3–7.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sternlicht H and Bakris GL: Management of
hypertension in diabetic nephropathy: How low should we go? Blood
Purif. 41:139–143. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen G, Yang JC, Zhang GX, Cheng Z and Du
X: Evaluation of six noninvasive methods for the detection of
fibrosis in Chinese patients with obesity and nonalcoholic fatty
liver disease. Obes Surg. 32:3619–3626. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cigrovski Berkovic M, Virovic-Jukic L,
Bilic-Curcic I and Mrzljak A: Post-transplant diabetes mellitus and
preexisting liver disease-a bidirectional relationship affecting
treatment and management. World J Gastroenterol. 26:2740–2757.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Younossi ZM: Non-alcoholic fatty liver
disease-a global public health perspective. J Hepatol. 70:531–544.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Collins FS and Tabak LA: Policy: NIH plans
to enhance reproducibility. Nature. 505:612–613. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Kautzky-Willer A, Abrahamian H, Weitgasser
R, Fasching P, Hoppichler F and Lechleitner M: Sex- and
gender-aspects in regard to clinical practice recommendations for
pre-diabetes and diabetes. Wien Klin Wochenschr. 128 (Suppl
2):S151–S158. 2016.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
12
|
Kautzky-Willer A, Harreiter J and Pacini
G: Sex and gender differences in risk, pathophysiology and
complications of type 2 diabetes mellitus. Endocr Rev. 37:278–316.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tanase DM, Gosav EM, Costea CF, Ciocoiu M,
Lacatusu CM, Maranduca MA, Ouatu A and Floria M: The intricate
relationship between type 2 diabetes mellitus (T2DM), insulin
resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J
Diabetes Res. 2020(3920196)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Machado MV and Diehl AM: Pathogenesis of
nonalcoholic steatohepatitis. Gastroenterology. 150:1769–1777.
2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Benedict M and Zhang X: Non-alcoholic
fatty liver disease: An expanded review. World J Hepatol.
9:715–732. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ioannou GN, Green P, Kerr KF and Berry K:
Models estimating risk of hepatocellular carcinoma in patients with
alcohol or NAFLD-related cirrhosis for risk stratification. J
Hepatol. 71:523–533. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Younossi ZM, Otgonsuren M, Henry L,
Venkatesan C, Mishra A, Erario M and Hunt S: Association of
nonalcoholic fatty liver disease (NAFLD) with hepatocellular
carcinoma (HCC) in the United States from 2004 to 2009. Hepatology.
62:1723–1730. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hua S, Qi Q, Kizer JR, Williams-Nguyen J,
Strickler HD, Thyagarajan B, Daviglus M, Talavera GA, Schneiderman
N, Cotler SJ, et al: Association of liver enzymes with incident
diabetes in US Hispanic/Latino adults. Diabet Med.
38(e14522)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fujiwara N, Qian T, Koneru B and Hoshida
Y: Omics-derived hepatocellular carcinoma risk biomarkers for
precision care of chronic liver diseases. Hepatol Res. 50:817–830.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
American Diabetes Association. 2.
Classification and diagnosis of diabetes: Standards of medical care
in diabetes-2018. Diabetes Care. 41 (Suppl 1):S13–S27.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sattari M, Bril F, Egerman R,
Kalavalapalli S and Cusi K: Relationship between non-alcoholic
fatty liver disease during pregnancy and abnormal glucose
metabolism during and after pregnancy. J Investig Med. 68:743–747.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hu ZH, Kong YY, Ren JJ, Huang TJ, Wang YQ
and Liu LX: Kidney and lung tissue modifications after BDL-induced
liver injury in mice are associated with increased expression of
IGFBPrP1 and activation of the NF-κB inflammation pathway. Int J
Clin Exp Pathol. 13:192–202. 2020.PubMed/NCBI
|
|
23
|
Liu YK, Xu H, Liu F, Tao R and Yin J:
Effects of serum cobalt ion concentration on the liver, kidney and
heart in mice. Orthop Surg. 2:134–140. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Roesler WJ, Pugazhenthi S and Khandelwal
RL: Hepatic glycogen metabolism in the db/db mouse. Mol Cell
Biochem. 92:99–106. 1990.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Michurina SV, Ishchenko IY, Arkhipov SA,
Cherepanova MA, Vasendin DV and Zavjalov EL: Apoptosis in the liver
of male db/db mice during the development of obesity and type 2
diabetes. Vavilovskii Zhurnal Genet Selektsii. 24:435–440.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhao W, Chen L, Zhou H, Deng C, Han Q,
Chen Y, Wu Q and Li S: Protective effect of carvacrol on liver
injury in type 2 diabetic db/db mice. Mol Med Rep.
24(741)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Berger C, Heyne HO, Heiland T, Dommel S,
Höfling C, Guiu-Jurado E, Lorenz J, Roßner S, Dannemann M, Kelso J,
et al: A novel compound heterozygous leptin receptor mutation
causes more severe obesity than in Leprdb/db mice. J
Lipid Res. 62(100105)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Blokh KO, Poltorak VV, Brindak OI and Tur
MI: Importance of db gene for the development of low dose
streptozotocin diabetes in C57BL/KsJ mice. Probl Endokrinol (Mosk).
34:73–75. 1988.PubMed/NCBI(In Russian).
|
|
29
|
Klessens CQF, Woutman TD, Veraar KAM,
Zandbergen M, Valk EJ, Rotmans JI, Wolterbeek R, Bruijn JA and
Bajema IM: An autopsy study suggests that diabetic nephropathy is
underdiagnosed. Kidney Int. 90:149–156. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lal A, Parai JL and Milroy CM: Liver
pathology in first presentation diabetic ketoacidosis at autopsy.
Acad Forensic Pathol. 6:271–280. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ma Y, Li W, Yazdizadeh Shotorbani P,
Dubansky BH, Huang L, Chaudhari S, Wu P, Wang LA, Ryou MG, Zhou Z
and Ma R: Comparison of diabetic nephropathy between male and
female eNOS-/-db/db mice. Am J Physiol Renal Physiol.
316:F889–F897. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lonardo A, Nascimbeni F, Ballestri S,
Fairweather D, Win S, Than TA, Abdelmalek MF and Suzuki A: Sex
differences in nonalcoholic fatty liver disease: State of the art
and identification of research gaps. Hepatology. 70:1457–1469.
2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kang DH, Yu ES, Yoon KI and Johnson R: The
impact of gender on progression of renal disease: Potential role of
estrogen-mediated vascular endothelial growth factor regulation and
vascular protection. Am J Pathol. 164:679–688. 2004.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shim GJ, Kis LL, Warner M and Gustafsson
JA: Autoimmune glomerulonephritis with spontaneous formation of
splenic germinal centers in mice lacking the estrogen receptor
alpha gene. Proc Natl Acad Sci USA. 101:1720–1724. 2004.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Singh SS, Roeters-van Lennep JE, Lemmers
RFH, van Herpt TTW, Lieverse AG, Sijbrands EJG and van Hoek M: Sex
difference in the incidence of microvascular complications in
patients with type 2 diabetes mellitus: A prospective cohort study.
Acta Diabetol. 57:725–732. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mauvais-Jarvis F, Manson JE, Stevenson JC
and Fonseca VA: Menopausal hormone therapy and type 2 diabetes
prevention: Evidence, mechanisms, and clinical implications. Endocr
Rev. 38:173–188. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Engin A: Non-alcoholic fatty liver
disease. Adv Exp Med Biol. 960:443–467. 2017.PubMed/NCBI View Article : Google Scholar
|
